Table 3—

Fasting lipids, insulin, glucose, insulin resistance, adipokines, and blood pressure in HIV-infected patients with and without metabolic syndrome by IDF criteria

IDF
ATPIII
Metabolic syndromeNo metabolic syndromeP valueMetabolic syndromeNo metabolic syndromeP value
n114674139649
Total cholesterol (mmol/l)5.6 ± 1.05.3 ± 2.00.15.8 ± 2.05.3 ± 1.50.002
LDL cholesterol (mmol/l)3.1 ± 1.03.0 ± 1.00.72.0 ± 1.03.1 ± 1.00.07
HDL cholesterol (mmol/l)0.97 ± 0.31.18 ± 0.40<0.00010.9 ± 0.31.2 ± 0.4<0.0001
Triglycerides (mmol/l)3.44 ± 2.02.60 ± 3.00.0064.3 ± 3.02.4 ± 3.0<0.0001
Glucose (mmol/l)5.80 ± 2.05.0 ± 1.0<0.00016.1 ± 2.04.9 ± 0.8<0.0001
Insulin (mIU/l)149 ± 15787 ± 138<0.0001181 ± 26277 ± 89<0.0001
C-peptide (ng/ml)2.5 ± 61.2 ± 1<0.00011.9 ± 2.01.3 ± 3.00.03
Insulin resistance (HOMA)6 ± 83 ± 6<0.00017.8 ± 122.5 ± 3.0<0.0001
hsCRP (mg/l)5.5 ± 7.03.9 ± 6.00.0034.7 ± 7.04.0 ± 6.00.25
Leptin (ng/ml)8 ± 94 ± 6<0.00016.3 ± 8.04.5 ± 6.00.006
Adiponectin (μg/ml)12 ± 815 ± 10<0.000115 ± 1018 ± 8<0.0001
  • Data are means ± SD. HOMA, homeostasis model assessment; hsCRP, high-sensitivity CRP.